Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Pfizer, Inc.
  6. Summary
    PFE   US7170811035

PFIZER, INC.

(PFE)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/14/2021 06/15/2021 06/16/2021 06/17/2021 06/18/2021 Date
39.63(c) 39.59(c) 39.3(c) 39.48(c) 38.81(c) Last
23 408 340 20 206 867 19 177 546 19 580 121 37 775 909 Volume
-1.30% -0.10% -0.73% +0.46% -1.70% Change
More quotes
Financials (USD)
Sales 2021 72 838 M - -
Net income 2021 17 466 M - -
Net Debt 2021 26 268 M - -
P/E ratio 2021 13,2x
Yield 2021 4,06%
Sales 2022 60 525 M - -
Net income 2022 16 082 M - -
Net Debt 2022 21 016 M - -
P/E ratio 2022 13,7x
Yield 2022 4,27%
Capitalization 217 B 217 B -
EV / Sales 2021 3,34x
EV / Sales 2022 3,94x
Nbr of Employees 78 500
Free-Float 59,2%
More Financials
Company
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines... 
Sector
Pharmaceuticals
Calendar
07/28Earnings Release
More about the company
Ratings of Pfizer, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about PFIZER, INC.
07:10aASTRAZENECAá : GSK to boost spending power of pharma business post break-up
RE
04:55aIndia Starts Free AstraZeneca, Bharat Biotech COVID-19 Jabs for Adults
MT
04:27aBIONTECHá : Philippines Buys 40 Million BioNTech/Pfizer COVID-19 Vaccine Shots
MT
04:04aASTRAZENECAá : India's vaccinations hit record with free COVID shots
RE
04:04aASTRAZENECAá : India's vaccinations hit record with free COVID shots
RE
12:24aSwitzerland To Begin COVID-19 Vaccinations For Ages 12 To 15
MT
06/21NZ regulator approves Pfizer vaccine for 12-15 year olds
RE
06/20PFIZERá : Ontario reports 318 new cases of COVID-19 as province prepares for Pfi..
AQ
06/20Philippines seals biggest COVID-19 vaccine order yet, for 40 mln Pfizer doses
RE
06/20Philippines seals deal for 40 mln Pfizer/BioNTech COVID-19 doses
RE
06/20Philippines' vaccine procurement chief confirms supply agreement with pfizer-..
RE
06/20Philippines signs deal for 40 mln Pfizer/BioNTech vaccine doses - report
RE
06/20Philippine government has signed a supply deal for 40 million doses of pfizer..
RE
06/19PFIZERá : Quebec pauses Pfizer shots at walk-in clinics for several days over de..
AQ
06/19PFIZERá : Aussie MP Hails Zimbabwe's Covid-19 Vaccination Campaign
AQ
More news
News in other languages on PFIZER, INC.
07:18aSTUDIE : Corona-Krise schiebt Biotech-Branche an
06:09aIMPFUNGEN FÜR ALLE MÖGLICH : Eine Million Buchungen in Großbritannien
03:37aCOVIDá : Sileri; su mix vaccini errore di comunicazione (Stampa)
06/20Revue de presse du dimanche 20 juin 2021
06/19Die Schlagzeilen der Sonntagspresse vom Sonntag, 20. Juni 2021
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 24
Average target price 42,34 $
Last Close Price 38,81 $
Spread / Highest target 36,6%
Spread / Average Target 9,10%
Spread / Lowest Target -7,24%
EPS Revisions
Managers and Directors
NameTitle
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER, INC.5.43%217 246
JOHNSON & JOHNSON2.92%426 557
ROCHE HOLDING AG12.70%325 803
NOVARTIS AG2.47%208 642
ABBVIE INC.5.57%199 795
ELI LILLY AND COMPANY29.44%198 668